CD274 and triple-negative breast carcinoma: However, breast cancers rarely exhibit microsatellite instability and PD-L1 expression has been inconsistently observed in immunogenic breast tumors [i.e., only 40% of triple-negative breast cancers (TNBC) are PD-L1 positive] (7–10).